Back to results
US 2024/0002854 A1Published application
Albumin Production and Cell Proliferation
AssigneeMina Therapeutics Limited
InventorPål Sætrom
Life of this patent
Estimating the term…
Abstract
The present invention provides short activating RNA molecules which up-regulate albumin production. The present invention also provides methods of up-regulating albumin production, such methods involving the use of short activating RNA molecules capable of increasing the expression of albumin. The present invention also provides the use of the short activating RNA molecules in therapy, such as treating or preventing a hyperproliferative disorder and/or a disorder characterised by hypoalbuminemia.
Claims13
1-21. (canceled)
A synthetic short activating RNA (saRNA) which up-regulates the expression of a target gene,
- wherein the target gene is CEBPA, albumin or HNF4a,
- wherein the saRNA comprises an antisense stand that is 13 nucleotides to 30 nucleotides in length, and
- wherein the antisense stand comprises a sequence that overlaps the promoter region of the target gene and a number of unpaired nucleotides at the 3′ end forming 3′ overhangs.
Dependencies are inferred from the claim text.